Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for K Pharma Inc. (4896:JPX), powered by AI.
K Pharma Inc. is currently trading at ¥664. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for K Pharma Inc. on Alpha Lenz.
View K Pharma Inc.'s valuation metrics on Alpha Lenz.
“K Pharma Inc.'s ROE is -56.4%. Explore profitability and growth together.”
Ask for details →K Pharma Inc. is a pioneering entity in the pharmaceutical industry, known for its robust research and development capabilities. The primary function of K Pharma Inc. is to discover, develop, and commercialize a wide range of pharmaceutical products aimed at treating various health conditions. Specializing in therapeutic areas such as oncology, immunology, and cardiovascular diseases, the company plays a significant role in advancing medical science and improving patient outcomes worldwide. K Pharma's innovative pipeline is indicative of its commitment to addressing unmet medical needs through cutting-edge biotechnology and precision medicine. The company's products are distributed across multiple channels, including hospitals, clinics, and pharmacies, ensuring broad access to critical treatments. With a commitment to sustainable practices, K Pharma Inc. also emphasizes environmentally conscious production processes. Its impact on the global healthcare landscape is marked by strategic collaborations, partnerships, and a strong presence in emerging and established markets, reinforcing its pivotal role in the pharmaceutical sector.
“K Pharma Inc.'s ROE is -56.4%. Explore profitability and growth together.”
Ask for details →K Pharma Inc. (ticker: 4896) is a company listed on JPX in the Healthcare sector (Biotechnology).
The current price is 664 with a P/E ratio of -x and P/B of -x.
ROE is -56.37%.